logo image
search icon
Baculovirus Expression System Market

Baculovirus Expression System Market Size, Share & Trends Analysis Report By Product Type (Baculovirus, Expression Vector, Reagents, Others), By Application (Therapeutics, Vaccines, Protein Purification, Others), By End User (Biopharmaceutical Companies, Research Institutes, Others), By Region, And By Segment Forecasts, 2023-2031.

Report ID : 2227 | Published : 2023-11-27 | Pages: 180 | Format: PDF/EXCEL

Baculovirus Expression System Market Size is valued at USD 351.48 Mn in 2022 and is predicted to reach USD 660.97 Mn by the year 2031 at a 7.35% CAGR during the forecast period for 2023-2031.

Baculovirus Expression System Market

The baculovirus vector system induces recombinant protein expression in insect cell cultures. It is one of the most adaptable and robust methods for the eukaryotic expression of recombinant proteins. This technique allows for the efficient manufacture of proteins with the appropriate post-translational modifications, making it ideal for use in research of protein function. Safety, quick vector synthesis, the flexibility to use serum-free medium, and efficient protein folding and post-translational modifications are just a few of the many benefits of this technology. Furthermore, the market for biosimilars has grown as the patents on several successful biologics have expired. The biosimilar industry is increasingly turning to baculovirus expression to speed up and reduce the cost of making biosimilar versions of antibodies and proteins. As a result, the baculovirus expression system market is anticipated to benefit from expanding the biologics and biosimilar industries.

However, market expansion is anticipated to be hampered by issues that include the high cost of research and development, the scarcity of supporting infrastructure, the high price of treatment, and the prevalence of market consolidation. Low-cost substitutes, stringent regulatory approvals, the high cost of protein therapy, and a lack of suitable infrastructure in low- and middle-income countries are all expected to slow market expansion over the next few years. The effects of COVID-19 on the market have been adverse. The suspension of elective surgical procedures hampered the potential for the need to expand. In addition, the market was hampered during this pandemic era by restrictions enacted in response to the movement. However, with the forthcoming easings, a recovery is anticipated in the market.

Competitive Landscape

Some Major Key Players In The Baculovirus Expression System Market:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Takara Bio
  • Agilent Technologies
  • Oxford Expression Technologies
  • Promega Corporation
  • Qiagen N.V.
  • Bio-Rad Laboratories
  • New England Biolabs
  • Genscript Biotech Corporation
  • Syngene International Limited
  • Sartorius AG
  • Aragen Bioscience
  • Vivopure
  • Creative Biogene
  • Absolute Antibody
  • Rockland Immunochemicals
  • Protein Technologies Inc.
  • Proteogenix
  • Virovek
  • Others

Market Segmentation:

The baculovirus expression system market is segmented based on product type, application, and end-use industry. According to product type, the market comprises baculovirus, expression vector, reagents, and others. By application, the market is segmented into therapeutics, Vaccines, Protein Purification, and Others. By end-use industry, the market is segmented into biopharmaceutical companies, research institutes, and others.

Based On The Product Type, The Expression Vectors Baculovirus Expression System Market Segment Is Accounted As A Major Contributor To The Baculovirus Expression System Market. 

The expression vectors baculovirus expression system category is likely to hold a significant global market share in 2022. Expression vectors have been used to transfer genes into plants and animals, resulting in transgenic species used in agriculture. Rice plants have been modified to produce beta-carotene, a precursor to vitamin A, using expression vectors.

Biopharmaceutical Segment To Witness Growth At A Rapid Rate.

The biopharmaceutical industry makes up the bulk of acrylic acid ester usage because many medicine manufacturers have developed efficient manufacturing procedures that help keep their goods affordable. Any group working to expand people's access to low-cost medical care may benefit, especially in countries like the US, Germany, the UK, China, and India.

In The Region, The North American Baculovirus Expression System Market Holds A Significant Revenue Share.

The North American baculovirus expression system market is expected to record the maximum market share in revenue in the near future. It can be attributed to the high concentration of top pharmaceutical firms, the massive funding of research and development, and the swift uptake of cutting-edge technologies. In addition, Asia Pacific is estimated to grow rapidly in the global baculovirus expression system market because global biopharma enterprises are increasingly outsourcing bioproduction in light of expanding demand for protein therapies, increasing investments in R&D infrastructure, and rising outsourcing rates.

Recent Developments:

  • In March 2022, ProteoGenix declared the introduction of the XtenCHOTM Transient Expression System. The novel proprietary expression host based on mammalian cells obtained up to ten times greater yields with reduced manual labour in comparison to established alternatives; this was due to the optimized metabolism and enhanced stability of the plasmid.   With the new CHO host, recombinant protein synthesis was intended to be simplified, and early-phase drug screening accelerated.

Baculovirus Expression System Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 351.48 Mn

Revenue Forecast In 2031

USD 660.97 Mn

Growth Rate CAGR

CAGR of 7.35 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Application, Product Type, End-Use

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek and othes

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Baculovirus Expression System Market Snapshot

Chapter 4. Global Baculovirus Expression System Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis

5.1. By Product Type, & Market Share, 2020 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product Type:

5.2.1. Baculovirus

5.2.2. Expression Vector

5.2.3. Reagents

5.2.4. Others

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis

6.1. By Application & Market Share, 2020 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Application:

6.2.1. Therapeutics

6.2.2. Vaccines

6.2.3. Protein Purification

6.2.4. Others

Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis

7.1. By End User & Market Share, 2020 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:

7.2.1. Biopharmaceutical Companies

7.2.2. Research Institutes

7.2.3. Others

Chapter 8. Baculovirus Expression System Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Product Type, 2019-2031

8.1.2. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By Application, 2019-2031

8.1.3. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031

8.1.4. North America Baculovirus Expression System Market revenue (US$ Million) estimates and forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2019-2031

8.2.2. Europe Baculovirus Expression System Market revenue (US$ Million) By Application, 2019-2031

8.2.3. Europe Baculovirus Expression System Market revenue (US$ Million) By End User, 2019-2031

8.2.4. Europe Baculovirus Expression System Market revenue (US$ Million) by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Product Type, 2019-2031

8.3.2. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By Application, 2019-2031

8.3.3. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) By End User, 2019-2031

8.3.4. Asia Pacific Baculovirus Expression System Market revenue (US$ Million) by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031

8.4.2. Latin America Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

8.4.3. Latin America Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

8.4.4. Latin America Baculovirus Expression System Market revenue (US$ Million) by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Product Type, (US$ Million) 2019-2031

8.5.2. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By Application, (US$ Million) 2019-2031

8.5.3. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) By End User, (US$ Million) 2019-2031

8.5.4. Middle East & Africa Baculovirus Expression System Market revenue (US$ Million) by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Thermo Fisher Scientific,

9.2.2. Merck KGaA,

9.2.3. Takara Bio,

9.2.4. Agilent Technologies,

9.2.5. Oxford Expression Technologies,

9.2.6. Promega Corporation,

9.2.7. Qiagen N.V.,

9.2.8. Bio-Rad Laboratories,

9.2.9. New England Biolabs,

9.2.10. Genscript Biotech Corporation,

9.2.11. Syngene International Limited,

9.2.12. Sartorius AG,

9.2.13. Aragen Bioscience,

9.2.14. Vivopure,

9.2.15. Creative Biogene,

9.2.16. Absolute Antibody,

9.2.17. Rockland Immunochemicals,

9.2.18. Protein Technologies Inc.,

9.2.19. Proteogenix,

9.2.20. Virovek

Segmentation Of The Baculovirus Expression System Market-

Baculovirus Expression System Market By Product Type-

  • Baculovirus
  • Expression Vector
  • Reagents
  • Others

Baculovirus Expression System Market Seg

Baculovirus Expression System Market By Application-

  • Therapeutics
  • Vaccines
  • Protein Purification
  • Others

Baculovirus Expression System Market By End User-

  • Biopharmaceutical Companies
  • Research Institutes
  • Others

Baculovirus Expression System Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Baculovirus Expression System Market?

Baculovirus Expression System Market expected to grow at a 7.35% CAGR during the forecast period for 2023-2031.

Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek and othes

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach